Harmony Biosciences Holdings, Inc. (HRMY)
40.51
+0.92
(+2.32%)
USD |
NASDAQ |
Dec 12, 16:00
40.50
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Total Assets (Quarterly): 1.208B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Halozyme Therapeutics, Inc. | 2.221B |
| Capricor Therapeutics, Inc. | 126.44M |
| Nurix Therapeutics, Inc. | 522.47M |
| Moderna, Inc. | 12.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 373.10M |
| Shareholders Equity (Quarterly) | 835.12M |
| Debt to Equity Ratio | 0.2719 |
| Current Ratio | 3.755 |
| Net Debt Paydown Yield | -0.10% |